2010-023749-30: Studio PKCT - Pharmacokinetics of chemotherapy when given concurrently with antiretroviral (Protocol no. CSL01). Studio PKCT – Farmacocinetica dei chemioterapici antitumorali quando somministrati in concomitanza con antiretrovirali (Protocollo nr. CSL01). |
|
|
| Completed | 4 | 12 | Europe | Solution for injection, Film-coated tablet, Tablet, Coated tablet, Capsule, hard, Gastro-resistant capsule, hard, Powder and solvent for solution for injection, Capsule, soft, DOXORUBICINA EBEWE*1F 50MG/25M, ISENTRESS*FL 180CPR RIV 400MG, INTELENCE*FL 120CPR 100MG, ZIAGEN*6BLISTER 10CPR 300MG, ZERIT*56CPS 30MG, ZERIT*56CPS 40MG, VIREAD*30CPR 245MG, VIDEX*30CPS GASTR 250MG, VIDEX*30CPS GASTR 400MG, TRUVADA*30CPR RIV 200MG/245MG, RETROVIR*60CPR 300MG, KIVEXA*BL 30CPR RIV 600MG+300M, FUZEON*SC 60FL POLV 90MG/ML, TELZIR*1FL 60CPR RIV 700MG, NORVIR*FL 84CPS MOLLI 100MG, REYATAZ*60CPS 200MG, PREZISTA*120CPR RIV 300MG, KALETRA*120CPR RIV 200MG+50MG, INVIRASE*FL 120CPR RIV 500MG, APTIVUS*FL 120CPS MOLLI 250MG, CELSENTRI*30CPR RIV 300MG, COMBIVIR*60CPR RIV 150MG+300MG, EMTRIVA*1BLIST 30CPS 200MG, EPIVIR*FL 30CPR RIV 300MG, VIRAMUNE*60CPR 200MG, SUSTIVA*30CPR RIV 600MG BLIST | FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR | patients with Hodgkin lymphoma and non-Hodgkin's lymphoma and HIV infection. pazienti affetti da linfoma Hodgkin e non Hodgkin e infezione da HIV. | | | | |
